ID

13604

Description

Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00513305

Lien

https://clinicaltrials.gov/show/NCT00513305

Mots-clés

  1. 19/02/2016 19/02/2016 -
Détendeur de droits

CC BY-NC 3.0

Téléchargé le

19 février 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Acute Myeloid Leukemia NCT00513305

Eligibility Acute Myeloid Leukemia NCT00513305

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient has confirmed acute myeloid leukemia (aml).
Description

the patient has confirmed acute myeloid leukemia (aml).

Type de données

boolean

Alias
UMLS CUI [1]
C0023467
the patient is unwilling or unable to tolerate conventional induction chemotherapy.
Description

the patient is unwilling or unable to tolerate conventional induction chemotherapy.

Type de données

boolean

Alias
UMLS CUI [1]
C0392920
the patient has no comorbid conditions that would limit life expectancy to less than 3 months.
Description

the patient has no comorbid conditions that would limit life expectancy to less than 3 months.

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
patient must meet specific laboratory parameters for study inclusion.
Description

patient must meet specific laboratory parameters for study inclusion.

Type de données

boolean

Alias
UMLS CUI [1]
C0022885
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
the patient has had previous cytotoxic chemotherapy for acute myeloid leukemia (aml) or myelodysplastic syndrome (mds).
Description

the patient has had previous cytotoxic chemotherapy for acute myeloid leukemia (aml) or myelodysplastic syndrome (mds).

Type de données

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0205156
previous treatment with low-dose cytarabine is not permitted.
Description

previous treatment with low-dose cytarabine is not permitted.

Type de données

boolean

Alias
UMLS CUI [1]
C0010711
the patient has a qt interval outside of the protocol-specified range.
Description

the patient has a qt interval outside of the protocol-specified range.

Type de données

boolean

Alias
UMLS CUI [1]
C0429028
the patient has laboratory values outside of protocol-specified ranges.
Description

the patient has laboratory values outside of protocol-specified ranges.

Type de données

boolean

Alias
UMLS CUI [1]
C0022885
the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.
Description

the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.

Type de données

boolean

Alias
UMLS CUI [1]
C0677881
UMLS CUI [2]
C0851346
UMLS CUI [3]
C1875319
the patient has uncontrolled, severe cardiovascular or pulmonary disease or other uncontrolled medical condition.
Description

the patient has uncontrolled, severe cardiovascular or pulmonary disease or other uncontrolled medical condition.

Type de données

boolean

Alias
UMLS CUI [1]
C0009488
the patient has known central nervous system involvement with aml.
Description

the patient has known central nervous system involvement with aml.

Type de données

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C0449389

Similar models

Eligibility Acute Myeloid Leukemia NCT00513305

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
acute myeloid leukemia
Item
the patient has confirmed acute myeloid leukemia (aml).
boolean
C0023467 (UMLS CUI [1])
conventional induction chemotherapy
Item
the patient is unwilling or unable to tolerate conventional induction chemotherapy.
boolean
C0392920 (UMLS CUI [1])
life expectancy
Item
the patient has no comorbid conditions that would limit life expectancy to less than 3 months.
boolean
C0023671 (UMLS CUI [1])
laboratory parameters
Item
patient must meet specific laboratory parameters for study inclusion.
boolean
C0022885 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
chemotherapy
Item
the patient has had previous cytotoxic chemotherapy for acute myeloid leukemia (aml) or myelodysplastic syndrome (mds).
boolean
C0392920 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
cytarabine
Item
previous treatment with low-dose cytarabine is not permitted.
boolean
C0010711 (UMLS CUI [1])
qt interval
Item
the patient has a qt interval outside of the protocol-specified range.
boolean
C0429028 (UMLS CUI [1])
laboratory values
Item
the patient has laboratory values outside of protocol-specified ranges.
boolean
C0022885 (UMLS CUI [1])
the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.
Item
the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.
boolean
C0677881 (UMLS CUI [1])
C0851346 (UMLS CUI [2])
C1875319 (UMLS CUI [3])
comorbidity
Item
the patient has uncontrolled, severe cardiovascular or pulmonary disease or other uncontrolled medical condition.
boolean
C0009488 (UMLS CUI [1])
central nervous system involvement
Item
the patient has known central nervous system involvement with aml.
boolean
C0023467 (UMLS CUI [1,1])
C0449389 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial